CLEMENTIA PHARMACEUTICALS
Clementia is a clinical-stage company innovating treatments for people with ultra-rare bone disorders. The company develops disease-modifying treatments for patients suffering from debilitating bone and other diseases with a high unmet medical need. The company's lead product candidate, palovarotene, is an oral small molecule that has shown potent activity in preventing abnormal new bone formation as well as fibrosis in a variety of tissues. Clementia Pharmaceuticals was founded in 2012 and is headquartered in Montréal, Quebec.
CLEMENTIA PHARMACEUTICALS
Industry:
Biopharma Biotechnology Medical
Founded:
2010-01-01
Address:
Montréal, Quebec, Canada
Country:
Canada
Website Url:
http://www.ipsen.com
Total Employee:
11+
Status:
Active
Contact:
(514) 940-3600
Email Addresses:
[email protected]
Total Funding:
92.5 M USD
Technology used in webpage:
SPF Apple Mobile Web Clips Icon Content Delivery Network Microsoft Exchange Online Amazon Office 365 Mail Microsoft Azure DNS BootstrapCDN Amazon Route 53 Sectigo SSL
Similar Organizations
Abwiz Bio
We provide researchers world-wide with top-quality monoclonal antibodies
Akston Biosciences
Akston Biosciences Corporation leverages its novel fusion protein platform to develop and manufacture new classes of biologics.
AlgaeCytes
AlgaeCytes uses a photobioreactor system and freshwater algal strains to produce high purity Omega 3 oils EPA.
Ansun BioPharma
Ansun BioPharma is a clinical-stage biopharmaceutical company focused on the development of host-directed anti-viral.
Asklepios BioPharmaceutical
Asklepios BioPharmaceutical is a biotechnology company developing adeno-associated virus (AAV) gene therapies for genetic disorders.
Axol Bioscience
Axol Bioscience sells live human cell cultures and provides services such as genome editing to researchers.
BioFeyn
BioFeyn is enhancing the efficiency and sustainability of marine ingredients for use in aquaculture.
BrainXell
BrainXell provides a range of high-purity, iPSC-derived human neurons for research and development with a focus on drug discovery.
Calimmune
Calimmune is a clinical-stage gene therapy company.
Celator Pharmaceuticals
Celator Pharmaceuticals is a biopharmaceutical company developing therapies to treat cancer, using the drug ratio technology platform.
ClostraBio
ClostraBio is a provider of a bio pharma company intended to develop therapeutics for food allergies.
Ella Biomedical
Ella is bringing mindfulness programs online to manage your pain.
Foresite Labs
Foresite Labs is a biotechnology company.
Genoa Pharmaceuticals
Genoa Pharmaceuticals develops therapies for the treatment of idiopathic pulmonary fibrosis.
Genome Profiling
Genome Profiling company focused on epigenetic biomarker discovery.
IDP Pharma
IDP Pharma is a first in class drug for multiple mieloma treatment, to set up new discovery programs.
InVivo
InVivo helps agriculture cooperation regain their rightful place in the global food value chain.
Jennerex Biotherapeutics
Jennerex is a clinical-stage biopharmaceutical company developing targeted oncolytic products for the treatment of cancer.
Joekai
Joekai is a specialty contract research organization that focuses on biological services in the area of CNS disorders.
Lineage Cell Therapeutics
Lineage Cell Therapeutics is a clinical-stage biotechnology company developing novel cellular therapies to treat unmet medical needs.
LiveLeaf
LiveLeaf develops therapeutic products designed to turn the biochemistry of plant immunity into sustainable one.
Naurex
Naurex is a clinical-stage company developing novel therapeutics for depression and other CNS disorders.
NGM Biopharmaceuticals
NGM Biopharmaceuticals is a drug discovery company developing biotherapeutics for the gastrointestinal endocrine system.
Nortis
Nortis is developing the next generation of invitro systems that will allow scientists to better understand the causes of human diseases.
Oisin Biotechnologies
Oisin Biotechnologies is a drug development company focused on mitigating the senolytic technology to combat age-related diseases.
PhaseBio Pharmaceuticals
PhaseBio is a clinical-stage biopharmaceutical company that develops drugs for cardiovascular diseases, endocrine, and metabolic disorders.
Profacgen
Profacgen is a state-of-the-art protein service provider.
ResQ Pharma
ResQ Pharma is a research & development company that develops drugs and therapies for treating lipophilic drug overdoses and poisonings.
Palisade Bio
Palisade Bio is a clinical-stage biopharmaceutical company developing novel therapies for acute and chronic gastrointestinal complications.
Seraph Biosciences
Seraph Biosciences is a developer of real-time pathogen detection systems used to treat infections.
Solaris Farm
High-Tech Hybrid Cannabis Greenhouse
Soligenix
Soligenix is a biopharmaceutical company that develops biodefense vaccines and therapeutics to treat rare diseases.
Spinnaker Biosciences
Spinnaker Biosciences specializes in offering ophthalmic drug delivery technologies.
Tierra Biosciences
Tierra Biosciences is a synthetic biology company that offers an AI-driven platform with a vast range of custom proteins for research.
Larimar Therapeutics
Larimar Therapeutics is a clinical-stage biotechnology company focused on developing treatments for complex rare diseases.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
New Enterprise Associates
New Enterprise Associates investment in Venture Round - Clementia Pharmaceuticals
BDC Healthcare Venture
BDC Healthcare Venture investment in Venture Round - Clementia Pharmaceuticals
RA Capital Management
RA Capital Management investment in Venture Round - Clementia Pharmaceuticals
EcoR1 Capital
EcoR1 Capital investment in Venture Round - Clementia Pharmaceuticals
UCB
UCB investment in Venture Round - Clementia Pharmaceuticals
Rock Springs Capital
Rock Springs Capital investment in Venture Round - Clementia Pharmaceuticals
OrbiMed
OrbiMed investment in Venture Round - Clementia Pharmaceuticals
Janus Capital Group
Janus Capital Group investment in Venture Round - Clementia Pharmaceuticals
BDC Healthcare Venture
BDC Healthcare Venture investment in Series A - Clementia Pharmaceuticals
OrbiMed
OrbiMed investment in Series A - Clementia Pharmaceuticals
Newest Events participated
Participated in 14th Annual International Pediatric Orthopaedic Symposium
on 2017-11-28 as sponsor
Official Site Inspections
http://www.ipsen.com
- Host name: server-3-167-112-108.iad55.r.cloudfront.net
- IP address: 3.167.112.108
- Location: Seattle United States
- Latitude: 47.6348
- Longitude: -122.3451
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98109
More informations about "Clementia Pharmaceuticals"
About Ipsen | Pioneering Biopharmaceutical Company - Global
In 1983, the group created the Fondation Ipsen under the aegis of the Fondation de France, to encourage exchanges between scientists in the field of life sciences. In 1986, the group …See details»
Ipsen: who we are
Ipsen’s products are registered in more than 100 countries. With 5,000 employees working to create value for patients and society around the world, we have global reach while remaining …See details»
Ipsen - Wikipedia
Ipsen is a French biopharmaceutical company headquartered in Paris, France, with a focus on drug development and commercialization in three therapeutic areas: oncology, rare diseases …See details»
Ipsen - The Org
Ipsen is a global specialty-driven biopharmaceutical group focused on innovation and Specialty Care. It develops and commercializes innovative medicines in three key therapeutic areas - Oncology, Neuroscience and Rare Disease. …See details»
Ipsen - Crunchbase Company Profile & Funding
Ipsen invests in R&D to advance scientific discovery and develop new therapeutic solutions across its focus areas. Clinical Trials: Ipsen conducts clinical trials to evaluate the safety and …See details»
Org Chart Ipsen - The Official Board
The organizational chart of Ipsen displays its 66 main executives including David Loew, Aymeric Le Chatelier and Sandra Silvestri. Toggle navigation The Official Board. Search. Search. Search by segment. Sign In. Business E-mail* …See details»
Ipsen Management Team | Org Chart - RocketReach
Ipsen employs 6,078 employees. The Ipsen management team includes David Loew (Chief Executive Officer) , Anne-Laure AMOROS (Vice President HR Specialty Care, Global Product …See details»
Ipsen: a dynamic, fast-growing specialty care …
Ipsen is the first company to test recombinant toxins in preclinical and phase 1 clinical studies 4; the strong internal expertise of its R&D teams has played a critical role in the establishment ...See details»
Ipsen – improving patient health outcomes - Ipsen Canada
Ipsen is dedicated to safeguarding and preserving our planet. The Generation Ipsen ESG sustainability strategy lays out ambitious goals for the company in each of our four pillars: …See details»
Ipsen Global: Heat treatment furnaces
Powering innovation worldwide. Expertly engineered vacuum and atmosphere furnaces, backed by support for the lifetime of your equipment. With excellence centers in Germany and the United States, our furnaces provide repeatable, …See details»
Ipsen Company Profile - Office Locations, Competitors, Revenue
Oct 29, 2024 Ipsen is a global specialty-driven biotechnological group with total sales exceeding €1.2 billion in 2014 in more than 115 countries, with a direct commercial presence in 30 …See details»
IPSEN Mission, Benefits, and Work Culture | Indeed.com
With total sales close to €2.576 billion in 2019, Ipsen markets more than 20 drugs in over 115 countries with a direct commercial presence in 37 countries. Our R&D focus is on developing …See details»
Ipsen USA Celebrates 2025 With Two Leadership Promotions
Cherry Valley, ILLINOIS (January 7, 2025) – Ipsen USA is proud to ring in the new year by announcing the promotion of two team members to new roles in 2025. These leadership …See details»
Ipsen: who we are - United States
Ipsen’s products are registered in 88 countries. With 5,000 employees working to create value for patients and society around the world, we have global reach while remaining an agile, mid …See details»
What is IPSEN? Company Culture, Mission, Values | Glassdoor
At Ipsen, our people are at the core of everything we do. We believe that fostering a culture of collaboration, excellence and impact is essential to achieving our mission of improving …See details»
Choose your country - Ipsen Academy
Ipsen Farmaceutica B.V. Taurusavenue 33b 2132 LS Hoofddorp Nederland Ipsen Group Ipsen NV/SA Guldensporenpark 87 9820 Merelbeke Belgium You are about to leave The Academy …See details»
Research & Development at Ipsen | Pioneering Biopharmaceutical …
Discover Ipsen's pioneering efforts in biopharmaceutical research and development. Committed to advancing science for better patient care. ... We are an organization deeply rooted in science; …See details»
Ipsen: Crafting Excellence Through ISO 9001 – Where Quality …
Ipsen Europe: Crafting Excellence Through ISO 9001 – Where Quality Meets Commitment! Recertification to ISO 9001 every three years is not only a challenge, but also a great …See details»
Four programs, one goal: exploring Ipsen’s Commercial Learning ...
4 days ago For Ipsen’s Learning & Development experts, the new program is a triumph of collaboration. “I truly encourage other departments to adopt this approach,” says Audrey …See details»
GloCal approach wins worldwide: a collaborative approach for …
4 days ago Ipsen’s certification program was crafted by the company’s global team,with contributions from over 15 local Commercial Learning & Development leaders. The UK’s …See details»